Our Blog | Biosimilars & Generics | AAM

The Medicare prescription drug program (Part D): Status report

Apr 19, 2022 | Monét Stanford

Challenges & Solutions for Prescription Drug Savings Identified by MedPAC

Apr 8, 2022 | Steven Selde

HHS OIG Report Demonstrates Need for Changes to Part D to Increase Biosimilar Use

KC, 73, Seattle, WA | High blood pressure / High cholesterol

Mar 30, 2022 | Erica Klinger

KC is Enjoying Life— “a Pretty Good Deal” on Prescriptions

Mar 24, 2022 | Sara Skubikowski

The Savings Add Up for Patients

Greg, 37, Los Angeles, CA | Ulcerative Colitis

Mar 23, 2022 | Erica Klinger

Greg is Treating His Ulcerative Colitis, and Enjoying a Slice or Two

Mar 18, 2022 | Monét Stanford

Senate Finance Hearing Highlights Ways to Reduce Drug Prices without Harming Patients

Eileen, 28, New York, NY | Crohn’s disease

Mar 15, 2022 | Erica Klinger

Eileen is Singing, Dancing and Taking Care of Herself with Biosimilars

Frances Zipp (Lachman Consultant Services), Susan Cantrell (AMCP) and Keren Haruvi (Sandoz) at WiHP Healthcare Leadership Luncheon

Mar 7, 2022 | Joanne Duncan

Women’s History Month: Honoring Yesterday’s and Today’s Leaders

Access! 2022 – AAM Annual Meeting

Feb 23, 2022 | Aquera Agee

Access! 2022: Recapping AAM’s Annual Meeting

Percy Julian working in a DePauw University lab, ca. 1930.

Feb 16, 2022 | Jewel Smith

Black History Month: 10 Pioneers to Celebrate

2021 State Savings Map

Feb 9, 2022 | Erica Klinger

State of the Union: Generic and Biosimilar Savings for States and Taxpayers

Access! 2022 – AAM Annual Meeting

Feb 6, 2022 | Aquera Agee

Seven Reasons to Join Us for Access! 2022